Search results

  1. Sanofi stops Multaq trial due to CV events; EMA expands review

    ... Sanofi-Aventis has pulled its Phase IIIb clinical trial comparing the efficacy of a 400 mg twice-daily dose of ... As a result, the European Medicines Agency (EMA) said that it will expand its review of the drug. While the Paris-based Sanofi said ...

    Kaitlyn Dmyterko - Jul 18, 2011

  2. Alsip named CMIO at UAB Health System

    ... in October, will work with the medical staff to develop the clinical strategy for the continued application of health IT at UAB. He will ensure that technology decisions are aligned with the health ...

    Bob Mitchell - Sep 19, 2011

  3. Simvastatin label revised, again

    ... the use of the highest approved dose of simvastatin after it was found to have a potential link to muscle damage in patients. The FDA ... other interacting drugs, there were no pharmacokinetic or clinical trial data to support the simvastatin dose reduction approved with ...

    Kaitlyn Dmyterko - Dec 15, 2011

  4. Smartronix expands health IT services with Cogon purchase

    To expand its health IT portfolio, Smartronix has acquired Cogon Systems, which will now exist as a ... continuity-of-care information, previous procedures and clinical notes. Cogon's VHN presently allows for the sharing of health ...

    Jeff Byers - Aug 12, 2010

  5. Amerinet selects 4medica as connectivity supplier

    ... Amerinet has selected  4medica as a healthcare IT connectivity supplier to the organization's 2,729 hospital members. ... provider. 4medica's Integrated Health Record (IHR) clinical integration tools for hospitals and health systems integrate ...

    Jeff Byers - Mar 30, 2011

  6. HIE market: Take a deep breath

    ... and business models begin integrating themselves into the clinical collective consciousness. And yet, rattling the IT cages most likely settles into creature comforts once the providers become ...

    Jeff Byers - Aug 23, 2011

  7. AJR: Skeletal imaging with 18F-NaF is 'superior' to standard tracers

    ... Roentgenology. Although not commonly used in current clinical practice, the PET agent 18F-NaF provides an “excellent ... quality obtained with 18F-NaF PET skeletal imaging makes it an attractive option for the evaluation of suspected bone trauma and ...

    Justine Varieur Cadet - Oct 02, 2011

  8. NCI names U of Utah a Center for Quantitative Imaging Excellence

    ... cancer centers. Once a center has earned CQIE certification, it is deemed "trial ready," and capable of conducting NCI-sponsored clinical trials that use advanced quantitative imaging. Mary C. Beckerle, ...

    Justine Varieur Cadet - Dec 14, 2011

  9. Calif. payors, providers unite for ACO initiative

    ... The healthcare entities will work together to share clinical and case management information and coordinate healthcare services. ... 1 and will continue for a minimum of 36 months. It is the parties' collective intent to extend the collaboration even longer in ...

    Jeff Byers - Feb 28, 2012

  10. AstraZeneca responds to FDA on ticagrelor

    ... CRL did not request AstraZeneca to conduct any further clinical trials as a prerequisite for approval of ticagrelor’s NDA. Once ... by the FDA, the agency will then conduct the review and deem it either a class 1 (two-month review cycle) or class 2 (six-month review ...

    Kaitlyn Dmyterko - Jan 25, 2011

Pages